Longfellow Investment Management’s West Pharmaceutical WST Stock Holding History

Longfellow Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-4	Closed	-$896	–	294
2025 Q1	$896	Hold	4	–	–	﹤0.01%	254
2024 Q4	$1.31K	Hold	4	–	–	﹤0.01%	246
2024 Q3	$1.2K	Hold	4	–	–	﹤0.01%	237
2024 Q2	$1.32K	Hold	4	–	–	﹤0.01%	226
2024 Q1	$1.58K	Hold	4	–	–	﹤0.01%	235
2023 Q4	$1.41K	Hold	4	–	–	﹤0.01%	213
2023 Q3	$1.5K	Hold	4	–	–	﹤0.01%	198
2023 Q2	$1.53K	Hold	4	–	–	﹤0.01%	225
2023 Q1	$1.39K	Hold	4	–	–	﹤0.01%	234
2022 Q4	$941	Buy	4 +1	+33%	+$237	﹤0.01%	252
2022 Q3	$1K	Hold	3	–	–	﹤0.01%	322
2022 Q2	$1K	Hold	3	–	–	﹤0.01%	356
2022 Q1	$2K	Hold	3	–	–	﹤0.01%	333
2021 Q4	$2K	Hold	3	–	–	﹤0.01%	342
2021 Q3	$2K	Hold	3	–	–	﹤0.01%	367
2021 Q2	$2K	Hold	3	–	–	﹤0.01%	382
2021 Q1	$1K	Hold	3	–	–	﹤0.01%	498
2020 Q4	$1K	Buy	+3	New	+$842	﹤0.01%	512

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Longfellow Investment Management's WST Position: Q2 2025 in Review

Longfellow Investment Management sold out of West Pharmaceutical (WST) in Q2 2025, closing a stake of 4 shares — an estimated $896 sold.

Longfellow Investment Management first reported a position in WST in Q4 2020 and held it in 18 quarters. The position peaked at $2K in Q1 2022. 730 funds tracked by Wall St. Rank hold WST as of Q2 2025.

Longfellow Investment Management reported no remaining West Pharmaceutical position as of Q2 2025 after selling out during the quarter.
Longfellow Investment Management sold 4 West Pharmaceutical shares in Q2 2025, an estimated $896.
Longfellow Investment Management first reported a position in West Pharmaceutical in Q4 2020 and held it in 18 quarters.
Longfellow Investment Management's West Pharmaceutical position peaked at $2K in Q1 2022.
730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2025.

Based on Longfellow Investment Management's 13F filing for Q2 2025, filed 12 Aug 2025.